⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MAZE News
Maze Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
MAZE
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
globenewswire.com
MAZE
Maze Therapeutics to Participate in Three Upcoming Investor Conferences
globenewswire.com
MAZE
Form 8-K
sec.gov
MAZE
Maze Therapeutics Announces Appointments to Its Board of Directors
globenewswire.com
MAZE
JNJ
GSK
MRK
Form 8-K
sec.gov
MAZE
Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
globenewswire.com
MAZE
IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight
globenewswire.com
NVS
VRTX
BIIB
VTRS
AZN
IONS
TAK
ARWR
BHVN
NVO
LLY
LXRX
XRTX
REGN
FMS
MDT
AMPH
DRCT
BMRC
MAZE
MazeBolt Named Best AI-Powered Vulnerability Management Solution in 2026 Cybersecurity Stars Awards
globenewswire.com
MAZE
Form 8-K
sec.gov
MAZE